Lipids & metabolic liver disease
American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults with Dyslipidemia – 2025 Update
Methodological detailsinternational multidisciplinary task force, algorithm update
- International multidisciplinary task force
- Algorithm update
Recommendations
As issued by the authors
Guiding principles for patient-centered management of dyslipidemia
Risk assessment and testing for dyslipidemia
Identifying genetic dyslipidemias
Specific lifestyle recommendations for adults with dyslipidemia
Targeting LDL-C with pharmacologic therapy for ASCVD prevention in adults
Approach to statin-associated muscle symptoms in adults
Management of adults with hypertriglyceridemia
Management of special populations with dyslipidemia (older adults, adults receiving transgender care or HIV control, adults with autoimmune disorders, survivors of childhood cancers, adults with organ transplantation)
Management of hypercholesterolemia in pregnant and lactating individuals
Management of hypertriglyceridemia in pregnant and lactating individuals
FDA-approved medications for dyslipidemia
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →